Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 2236-2237, 2004; 10.1373/clinchem.2004.042978
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khalil, O. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khalil, O. S.
Related Collections
Right arrow Point-of-Care Testing
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:2236-2237.)
© 2004 American Association for Clinical Chemistry, Inc.


Editorials

Noninvasive Photonic-Crystal Material for Sensing Glucose in Tears

Omar S. Khalil

1 Abbott Laboratories, Diagnostics Division, 100 Abbott Park Rd., Abbott Park, IL 60064, E-mail Omar.khalil@abbott.com

The first 20% of the full text of this article appears below.

Most noninvasive (NI) methods for the determination of glucose either detect a small specific glucose signal or measure the effect of glucose on a tissue optical property (1)(2). A recent review identified the three main issues in NI glucose measurements as specificity, compartmentalization of glucose values, and calibration (1). This editorial discusses a photonic crystal method (3), with respect to these issues.

Asher’s group have developed a novel photonic sensing material that responds to glucose concentrations via diffraction of visible light. Polymerized crystalline colloidal arrays (PCCAs) are periodic crystalline lattices of polystyrene microspheres polymerized within thin hydrogel films (3)(4)(5)(6)(7). The arrays are brightly colored and act as diffraction gratings for white light according to the Bragg diffraction equation (4)(5):

(1)
In Eq. 1Up , n is the refractive index of the system (medium, hydrogel, and colloids), d is the spacing between the diffracting planes, {lambda} is the diffracted wavelength, and {Theta} is the glancing angle between the incident light and the diffracting planes. A change in electric charge in the PCCAs resulting from binding of molecular or ionic species causes changes the spacing, d, and there is a subsequent wavelength shift, {Delta}{lambda}, of the light reflected off the array.

Asher’s group have constructed a photonic glucose sensor in the form of thin acrylamide PCCA hydrogel films that contain glucose molecular recognition elements (3)(6)(7). Phenylboronic . . . [Full Text of this Article]




eLetters:

Read all eLetters

Response to your editorial on PCCA glucose sensors
Anjal C Sharma
Clinical Chemistry Online, 28 Jan 2005 [Full text]
Response to comments on the Photonic Crystal Glucose-sensor Editorial
Omar S Khalil
Clinical Chemistry Online, 2 Feb 2005 [Full text]
Re: Response to your editorial on PCCA glucose sensors
sanford a. asher
Clinical Chemistry Online, 28 Mar 2005 [Full text]
Re: Re: Response to your editorial on PCCA glucose sensors
Anjal C. Sharma
Clinical Chemistry Online, 19 May 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.